AI assistant
Sending…
GlaxoSmithKline PLC — Director's Dealing 2019
Feb 11, 2019
5262_dirs_2019-02-11_767ee1c8-3108-416a-9be5-d43329bba76b.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6575P
GlaxoSmithKline PLC
11 February 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
| 1. | Details of PDMR/person closely associated with them ('PCA') | ||||
| a) | Name | Mrs Denise Connor | |||
| b) | Position/status | PCA of Mr Roger Connor (President, Global Vaccines) | |||
| c) | Initial notification/ amendment |
Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | GlaxoSmithKline plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
|||
| b) | Nature of the transaction | Transfer of 6,000 Ordinary Shares to spouse for nil consideration. No change in beneficial ownership. |
|||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| £0.00 | 6,000 | ||||
| d) | Aggregated information | n/a (single transaction) | |||
| Aggregated volume Price | |||||
| e) | Date of the transaction | 2019-02-08 | |||
| f) | Place of the transaction | n/a |
| Details of PDMR/person closely associated with them ('PCA') | |||||
| a) | Name | Mr Roger Connor | |||
| b) | Position/status | President, Global Vaccines | |||
| c) | Initial notification/ amendment |
Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | GlaxoSmithKline plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
|||
| b) | Nature of the transaction | Receipt of 6,000 Ordinary Shares from spouse for nil consideration. | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| £0.00 | 6,000 | ||||
| d) | Aggregated information | n/a (single transaction) | |||
| Aggregated volume Price | |||||
| e) | Date of the transaction | 2019-02-08 | |||
| f) | Place of the transaction | n/a |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHLFLFFKLFXBBQ
More from GlaxoSmithKline PLC
Report Publication Announcement
2026
May 22
Regulatory Filings
2026
May 22
Director's Dealing
2026
May 20
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 20
Director's Dealing
2026
May 19
Regulatory Filings
2026
May 19
Transaction in Own Shares
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18